Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
- PMID: 15031212
- DOI: 10.1182/blood-2004-02-0434
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
Abstract
Procoagulant activity on tumor cells can enhance their ability to spread via the circulation to colonize distant organs. Toward defining the relative importance of the main host responses to coagulation for hematogenous metastasis, we examined lung metastases after intravenous injection of melanoma cells in Nf-E2(-/-) mice, which have virtually no circulating platelets; Par4(-/-) mice, which have platelets that fail to respond to thrombin; Par1 and Par2(-/-) mice, which have markedly attenuated endothelial responses to coagulation proteases; and Fib(-/-) mice, which lack fibrinogen. In a severe combined immunodeficiency (SCID) background, median lung tumor count in Nf-E2(-/-), Par4(-/-), and Fib(-/-) mice was 6%, 14%, and 24% of wild type, respectively; total tumor burden was only 4%, 9%, and 3% of wild type, respectively. Similar results were seen in a syngeneic C57BL6 background. By contrast, deficiencies of protease-activated receptor 1 (PAR1) or PAR2 did not provide protection. These results provide strong genetic evidence that platelets play a key role in hematogenous metastasis and contribute to this process by both thrombin-dependent and -independent mechanisms. Importantly, PAR4 heterozygosity conferred some protection against metastasis in this model. Thus even partial attenuation of platelet function may be sufficient to provide benefit.
Similar articles
-
Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.Dongwuxue Yanjiu. 2014 Sep;35(5):420-5. doi: 10.13918/j.issn.2095-8137.2014.5.420. Dongwuxue Yanjiu. 2014. PMID: 25297082 Free PMC article.
-
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L788-98. doi: 10.1152/ajplung.00226.2006. Epub 2006 Dec 1. Am J Physiol Lung Cell Mol Physiol. 2007. PMID: 17142351
-
Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.Mol Cancer Res. 2004 Jul;2(7):395-402. Mol Cancer Res. 2004. PMID: 15280447
-
Molecular mechanisms regulating Proteinase-Activated Receptors (PARs).FEBS J. 2021 Apr;288(8):2697-2726. doi: 10.1111/febs.15829. Epub 2021 Apr 6. FEBS J. 2021. PMID: 33742547 Review.
-
PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.Cancer Res. 2011 Nov 1;71(21):6561-6. doi: 10.1158/0008-5472.CAN-11-1432. Epub 2011 Oct 18. Cancer Res. 2011. PMID: 22009534 Free PMC article. Review.
Cited by
-
Platelets and Metastasis: New Implications of an Old Interplay.Front Oncol. 2020 Sep 18;10:1350. doi: 10.3389/fonc.2020.01350. eCollection 2020. Front Oncol. 2020. PMID: 33042789 Free PMC article. Review.
-
The prothrombotic activity of cancer cells in the circulation.Blood Rev. 2016 Jan;30(1):11-9. doi: 10.1016/j.blre.2015.07.001. Epub 2015 Jul 14. Blood Rev. 2016. PMID: 26219246 Free PMC article. Review.
-
NF-E2 p45 is important for establishing normal function of platelets.Mol Cell Biol. 2013 Jul;33(14):2659-70. doi: 10.1128/MCB.01274-12. Epub 2013 May 6. Mol Cell Biol. 2013. PMID: 23648484 Free PMC article.
-
Cancer metastasis chemoprevention prevents circulating tumour cells from germination.Signal Transduct Target Ther. 2022 Oct 2;7(1):341. doi: 10.1038/s41392-022-01174-w. Signal Transduct Target Ther. 2022. PMID: 36184654 Free PMC article. Review.
-
Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.J Gastroenterol. 2013 Apr;48(4):526-34. doi: 10.1007/s00535-012-0656-2. Epub 2012 Aug 22. J Gastroenterol. 2013. PMID: 22911171
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases